Causes and predictors of 30‐day readmission after cardiovascular implantable electronic devices implantation: Insights from Nationwide Readmissions Database

Causes and predictors of 30‐day readmission after cardiovascular implantable electronic devices... 1INTRODUCTIONHospital readmissions are a significant source of patient morbidity and put a significant drain on health care resources. Studies have shown that readmissions not only expose the patients to nosocomial infections but also are a considerable source of mental stress. Readmissions significantly amplify the cost of health care in the United States, with Medicare sustaining the largest portion of cost (∼58%), followed by private insurances (∼20%) and Medicaid (∼18%). To reduce the financial burden of these readmissions, the Affordable Care Act (ACA) launched the Hospital Readmission Reduction Program (HRRP), providing financial incentives to health care institutions with low 30‐day readmission rates for certain medical conditions and penalizing those with excess readmissions.Cardiovascular implantable electronic devices (CIEDs) are an established therapy for treatment of patients with lethal ventricular arrhythmias, symptomatic brady‐arrhythmias, and for those with advanced congestive heart failure (CHF). The use of these devices has increased substantially in the last two decades, and their use is expected to increase even more in coming years due to evolving guidelines for device‐based therapy for cardiac rhythm abnormalities in the aging U.S. population.Because of its magnitude and impact on the overall cost of health care, there is a need to assess the national http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Cardiovascular Electrophysiology Wiley

Causes and predictors of 30‐day readmission after cardiovascular implantable electronic devices implantation: Insights from Nationwide Readmissions Database